United Kingdom· GB-APID-9142711000001109
Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules
A medicinal product containing papaveretum + hyoscine hydrobromide, registered in United Kingdom by Martindale Pharmaceuticals Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Papaveretum + Hyoscine hydrobromide
- Manufacturer
- Martindale Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5014124178304
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/50f4ccf8-d18a-44ba-8f35-fa250836ee20 GET /v1/drugs/50f4ccf8-d18a-44ba-8f35-fa250836ee20?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "9142711000001109",
"desc": "Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd)",
"form": "Solution for injection",
"vpid": "36025411000001105",
"source": "dmd",
"vtm_id": "13297501000001108",
"strength": "400 microgram",
"substance": "Papaveretum + Hyoscine hydrobromide",
"ingredient": "Hyoscine hydrobromide",
"supplier_code": "3146701000001109"
}See everything about papaveretum + hyoscine hydrobromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.